Treating multiple myeloma in the era of new drugs: What is the right choice?

J Oncol Pharm Pract. 2023 Jul;29(5):1234-1236. doi: 10.1177/10781552231176499. Epub 2023 May 15.

Authors

Gianluca Perego¹, Laura Paris², Silvia Nozza¹, Paola Stefanoni², Michela Franzin¹

Affiliations

¹ Pharmacy Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
² Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.

PMID: 37186789
DOI: 10.1177/10781552231176499

No abstract available

Keywords: New drugs; newly diagnosed multiple myeloma; relapsed and refractory multiple myeloma.

MeSH terms

Drug Resistance, Neoplasm
Humans
Multiple Myeloma* / drug therapy
Thalidomide / therapeutic use

Substances

Thalidomide